Atossa Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.7613.411.860.53
Price/Sales ratio
N/A1.760.790.28
Earnings per Share (EPS)
$-0.27$0.05$0.40$1.43

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.34-0.57-0.65-0.37-0.37-0.77-0.50-9.08-2.55-3.68-2.43-0.77
Price/Sales ratio
65.355.17KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
3.612.431.340.430.481.010.391.350.561.21794.210.48
Price/Cash Flow ratio
-3.25-0.65-0.77-0.46-0.47-1.46-0.92-11.35-3.23-5.29K-8.63-1.46
Price/Free Cash Flow ratio
-3.15-0.64-0.77-0.46-0.46-1.46-0.92-11.35-3.22-5.29K-8.62-1.46
Price/Earnings Growth ratio
0.180.060.000.000.000.020.060.10-0.15-0.250.210.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
35.23%-7431.91%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-2783.97%-725746.18%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-2786.92%-725721.67%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-2786.92%-896491.63%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-16.05%-23.52%27.65%-9.14%0.25%0.69%-18.34%1.03%2.71%N/AN/A0.69%
Return on Assets
-124.59%-252.43%-153.67%-99.49%-97.30%-118.97%-49.25%-14.58%-21.23%-31.26%-31099.63%-118.97%
Return On Equity
-154.32%-421.20%-205.63%-117.06%-129.52%-131.04%-77.66%-14.91%-22.23%-33.06%-39.46%-129.52%
Return on Capital Employed
-153.32%-340.98%-257.29%-110.23%-129.86%-131.12%-53.76%-14.85%-23.47%-34.47%-16570.30%-131.12%
Liquidity Ratios
Current Ratio
4.101.713.106.443.9610.822.72N/AN/AN/A21.223.96
Quick Ratio
4.081.713.106.193.7410.092.6044.3520.4817.3219.913.74
Cash ratio
3.831.482.895.883.569.512.5243.6219.9116.8919.913.56
Days of Sales Outstanding
206.77N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
42.63N/AN/A865.695.11K6.72K15.06K41.22K188.93K23.59KN/A6.72K
Operating Cycle
249.40N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
636.822.24K305.87947.632.91K2.02K12.44K27.24K135.27K12.79KN/A2.02K
Cash Conversion Cycle
-387.42-2.24KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.000.00N/AN/AN/A0.040.00
Debt Equity Ratio
N/AN/AN/AN/AN/A0.000.00N/AN/AN/A0.040.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.000.00N/AN/AN/AN/A0.00
Interest Coverage Ratio
-779.36N/AN/A-37.27N/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-231.85-640.90N/AN/AN/AN/A-231.85
Company Equity Multiplier
1.231.661.331.171.331.101.571.021.041.051.041.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-20.06-7.93KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.001.0011.011.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-231.85-640.90N/AN/AN/AN/A-231.85
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-231.85-640.90N/AN/AN/AN/A-231.85
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A